Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma

Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma

Abstract Background Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma which possess highly aggressive and heterogeneous. Despite advances in understanding heterogeneity and development of novel targeted agents, the prognosis of DLBCL patients remains unsatisfied. Lipids are c...

Full description

Saved in:
Bibliographic Details
Main Authors: Cancan Wang, Ran Zhang, Huan Zhang, Haixia Gao, Yubing Zhu, Lichao Jiao, Zhiqiang Yi, Meiyu Zhou, Xinxia Li
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Molecular Medicine
Subjects:
Lipid metabolism
DLBCL
Tumor immune microenvironment
Prognosis
Online Access:https://doi.org/10.1186/s10020-024-00988-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items